Incyte (INCY) EPS (Basic) (2010 - 2026)

Incyte (INCY) posted EPS (Basic) of $1.52 for Q1 2026, down 0.75% on a QoQ basis from $1.53 in Q4 2025, and up 86.32% year-over-year from $0.82 in Q1 2025.

Incyte (INCY) EPS (Basic) (2010 - 2026) Analysis & Trends

Incyte's EPS (Basic) history runs 17 years deep, the most recent figure standing at $1.52 for Q1 2026.

  • Quarterly EPS (Basic) rose 86.32% year-over-year to $1.52 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.18 (up 6441.29% YoY) and the FY2025 annual result came in at $6.59, up 4085.58% from the prior year.
  • EPS (Basic) was $1.52 for Q1 2026 at Incyte, down from $1.53 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $2.17 in Q3 2025 and bottomed at -$2.04 in Q2 2024.
  • A 5-year average of $0.74 and a median of $0.76 in 2023 frame the typical range for EPS (Basic).
  • Peak annual rise in EPS (Basic) reached 675.92% in 2024, while the deepest fall reached 323.5% in 2024.
  • Incyte's EPS (Basic) stood at $0.13 in 2022, then soared by 601.38% to $0.9 in 2023, then grew by 8.05% to $0.97 in 2024, then surged by 57.81% to $1.53 in 2025, then retreated by 0.75% to $1.52 in 2026.
  • Business Quant data shows INCY's EPS (Basic) at $1.52 in Q1 2026, $1.53 in Q4 2025, and $2.17 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 1.52

Historic Data

Download Data
DateValue
Mar 31, 2026 1.52
Dec 31, 2025 1.53
Sep 30, 2025 2.17
Jun 30, 2025 2.09
Mar 31, 2025 0.82
Dec 31, 2024 0.97
Sep 30, 2024 0.55
Jun 30, 2024 -2.04
Mar 31, 2024 0.76
Dec 31, 2023 0.90
Sep 30, 2023 0.76
Jun 30, 2023 0.91
Mar 31, 2023 0.10
Dec 31, 2022 0.13
Sep 30, 2022 0.51
Jun 30, 2022 0.73
Mar 31, 2022 0.17
Dec 31, 2021 2.56
Sep 30, 2021 0.82
Jun 30, 2021 0.68